↓ Skip to main content

KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases

Overview of attention for article published in American Journal of Kidney Diseases, June 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#24 of 5,480)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
33 news outlets
blogs
1 blog
twitter
133 X users
facebook
1 Facebook page

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases
Published in
American Journal of Kidney Diseases, June 2023
DOI 10.1053/j.ajkd.2023.02.003
Pubmed ID
Authors

Laurence H Beck, Isabelle Ayoub, Dawn Caster, Michael J Choi, Jason Cobb, Duvuru Geetha, Michelle N Rheault, Shikha Wadhwani, Timothy Yau, William L Whittier

Abstract

The KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases represents the first update to this set of recommendations since the initial set of KDIGO guideline recommendations was published in 2012. The pace of growth in our molecular understanding of glomerular disease has quickened and a number of newer immunosuppressive and targeted therapies have been introduced since the original set of guideline recommendations, making such an update necessary. Despite these updates, many areas of controversy remain. In addition, further updates since the publication of KDIGO 2021 have occurred which this guideline does not encompass. With this commentary, the KDOQI work group has generated a chapter-by-chapter companion opinion article that provides commentary specific to the implementation of the KDIGO 2021 guideline in the United States.

X Demographics

X Demographics

The data shown below were collected from the profiles of 133 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 8%
Other 3 6%
Researcher 3 6%
Lecturer 2 4%
Unspecified 2 4%
Other 6 12%
Unknown 29 59%
Readers by discipline Count As %
Medicine and Dentistry 5 10%
Nursing and Health Professions 4 8%
Unspecified 2 4%
Biochemistry, Genetics and Molecular Biology 2 4%
Agricultural and Biological Sciences 1 2%
Other 5 10%
Unknown 30 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 329. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2024.
All research outputs
#102,636
of 25,641,627 outputs
Outputs from American Journal of Kidney Diseases
#24
of 5,480 outputs
Outputs of similar age
#2,267
of 380,135 outputs
Outputs of similar age from American Journal of Kidney Diseases
#1
of 46 outputs
Altmetric has tracked 25,641,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,480 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 380,135 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.